› Forums › General Melanoma Community › Melanoma In Situ
- This topic has 3 replies, 2 voices, and was last updated 5 years, 10 months ago by
Sandaman3.
- Post
-
- July 5, 2019 at 7:50 pm
Just diagnosed and confused as to how they determine in situ status from a shave biopsy?My path report states:
Diagnosis
Skin, left posterior shoulder:
-Melanoma in situ, superficial spreading pattern, present at peripherial marginPeter George Pavlidakey MD
(The Gross/Microscopic exams or the Gross Only specimen have been reviewed
and interpreted by the undersigned pathologist)
(Electronically signed by)
Verified: 07/01/19 16:22
PGP/PGPPathologist Comment
A sox-10 immunostain and multiple deeper level sections fails to reveal a invasive component.
The findings were discussed with Dr Kole on 7/1/19.Specimen ID
Left posterior shoulder
Clinical Information
Asymmetric brown macule on left posterior shoulder, lentigo vs nevus vs melanoma
Gross Description
The specimen is received in a single container of formalin labeled patient’s name, medical record number and is designated “left posterior shoulder”. Received is a tan dark brown shave of skin measuring 0.8 x 0.7 x 0.1 cm. The surgical margin is inked black. The specimen is bisected and submitted entirely in cassette A1.
UABDERM
James Moreno, BS/Peter George Pavlidakey, MD
6/27/2019 12:19:30 CDTI am having a wide excision next week and have been told that should be all that is needed along with 3 month follow ups.
Thanks for any feedback!
- Replies
-
-
- July 6, 2019 at 11:25 pm
Sorry to hear about your diagnosis.
I encourage you to ask if your tissues was sent for genetic testing, especially for BRAF mutation. It would be very helpful information for future treatment options.
Will you be following up with an oncologist who specializes in melanoma? The protocols are changing fast.
Sending light your way,
EllieEllie S
-
- July 7, 2019 at 12:02 am
Ellie,Thanks for the response. I am not sure if my sample was sent for BRAF testing but I doubt it was. It looks like the protocol is not to send it without advanced disease.
Do you normally see it tested with in situ? Does BRAF testing tell you if you will have a higher chance of metastatic disease?
In looking at posts here and feedback from my derm The diagnosis is 99-100 % survival at 5 years. With that said the derm wants to see me every 3 months for at least 2 years.
-
- July 17, 2019 at 4:13 am
Update from my earlier post. I had a WLE to .5 cm margins and the pathology came back with melanoma in situ at all margins. The surgeon said it was “statistically “ unlikely that this would happen but it did so they will go back in and take out wider margins.How common is this and should I be concerned about the breadth of the melanoma spread? Also, would this make it more likely that melanoma is growing elsewhere on my body simultaneously?
Thanks for any responses.
-
- You must be logged in to reply to this topic.